Literature DB >> 27344043

Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis.

Dorothee Cäcilia Spille1, Katharina Heß1, Cristina Sauerland2, Nader Sanai3, Walter Stummer4, Werner Paulus1, Benjamin Brokinkel5.   

Abstract

OBJECTIVE: In meningioma, correlation of brain invasion with prognosis and clinical variables remains controversial.
METHODS: Correlation of brain invasion with clinical and histopathologic variables was investigated in 467 patients with primary intracranial meningioma.
RESULTS: Diffuse (n = 3; 10%), clusterlike (n = 11; 34%) or fingerlike (n = 18; 56%) invasion was detected in 32 patients (7%). Brain invasion was more common in males than in females (13% vs. 5%; odds ratio, 2.75; 95% confidence interval, 1.29-5.89; P = 0.009) and pattern of invasion differed between genders (P = 0.037). Brain invasion was absent in 401 benign meningiomas and present in 48% of 60 atypical (n = 29) and 50% of 6 anaplastic (n = 3) meningiomas (P < 0.001) but was independent of tumor location and extent of resection. Progression occurred in 11% and was more frequent (31% vs. 15%; P = 0.036) in invasive than in noninvasive tumors, but only after gross total resection and in univariate analyses, and independent of invasion pattern. In atypical meningiomas, frequency of adjuvant irradiation was similar comparing invasive and noninvasive tumors and grading solely based on brain invasion (n = 20; 33%), other World Health Organization (WHO) criteria (n = 31; 52%) or a combination of both (n = 9; 15%). Risk of recurrence was lower (hazard ratio, 0.258, 95% confidence interval, 0.09-0.734; P = 0.011) when grading exclusively based on brain invasion than when further WHO criteria were in addition present and the progression-free interval among the first was similar to benign tumors.
CONCLUSIONS: Brain invasion and its patterns are correlated to gender. In contrast to the current WHO classification, invasion was associated with recurrence only after gross total resection and not independent of further histopathologic criteria of atypia.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain invasion; Gender; Meningioma; Prognosis

Mesh:

Year:  2016        PMID: 27344043     DOI: 10.1016/j.wneu.2016.06.055

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  24 in total

Review 1.  Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Brain Tumor Pathol       Date:  2021-01-06       Impact factor: 3.298

Review 2.  Diagnostic challenges in meningioma.

Authors:  Martha Nowosielski; Norbert Galldiks; Sarah Iglseder; Philipp Kickingereder; Andreas von Deimling; Martin Bendszus; Wolfgang Wick; Felix Sahm
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

3.  Brain invasion in meningiomas: does surgical sampling impact specimen characteristics and histology?

Authors:  Maximilian Timme; Christian Thomas; Dorothee Cäcilia Spille; Walter Stummer; Heinrich Ebel; Christian Ewelt; Franz-Josef Hans; Uta Schick; Maximilian Puchner; Uwe Wildförster; Bernhard Bruns; Hans Axel Trost; Markus Holling; Oliver Grauer; Katharina Hess; Benjamin Brokinkel
Journal:  Neurosurg Rev       Date:  2019-06-03       Impact factor: 3.042

4.  The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?

Authors:  Kira Marie Voß; Dorothee Cäcilia Spille; Cristina Sauerland; Eric Suero Molina; Caroline Brokinkel; Werner Paulus; Walter Stummer; Markus Holling; Astrid Jeibmann; Benjamin Brokinkel
Journal:  J Neurooncol       Date:  2017-05-19       Impact factor: 4.130

Review 5.  Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options.

Authors:  Chaoying Qin; Meng Huang; Yimin Pan; Yuzhe Li; Wenyong Long; Qing Liu
Journal:  Brain Tumor Pathol       Date:  2021-04-26       Impact factor: 3.298

Review 6.  Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review.

Authors:  Benjamin Brokinkel; Katharina Hess; Christian Mawrin
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

7.  Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.

Authors:  Annamaria Biczok; Christine Jungk; Rupert Egensperger; Andreas von Deimling; Bogdana Suchorska; Joerg C Tonn; Christel Herold-Mende; Christian Schichor
Journal:  J Neurooncol       Date:  2019-11-11       Impact factor: 4.130

8.  Atypical meningioma-is it time to standardize surgical sampling techniques?

Authors:  Michael D Jenkinson; Thomas Santarius; Gelareh Zadeh; Kenneth D Aldape
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

9.  Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma.

Authors:  Antonio Dono; Ankush Chandra; Leomar Y Ballester; Yoshua Esquenazi
Journal:  Neurosurgery       Date:  2021-06-15       Impact factor: 4.654

10.  EANO guideline on the diagnosis and management of meningiomas.

Authors:  Roland Goldbrunner; Pantelis Stavrinou; Michael D Jenkinson; Felix Sahm; Christian Mawrin; Damien C Weber; Matthias Preusser; Giuseppe Minniti; Morten Lund-Johansen; Florence Lefranc; Emanuel Houdart; Kita Sallabanda; Emilie Le Rhun; David Nieuwenhuizen; Ghazaleh Tabatabai; Riccardo Soffietti; Michael Weller
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.